glp-1 and suicidal ideation A recent post hoc analysis published in Obesity found tirzepatide vs. placebo was not associated with increased risk of depression symptoms. Rates of behavior were low and similar to TGA issues safety warning for

Retatrutide is not FDA-approved and cannot be obtained through standard prescriptions

each dose is drawn at 20 units on a U-100 insulin syringe

Front Physiol 2019;9:1-13

You should seek immediate medical attention if dark stools are accompanied by any of the following symptoms: Dizziness, light-headedness, or fainting Rapid heartbeat or palpitations Shortness of breath or chest pain Vomiting blood or material resembling coffee grounds Severe or persistent abdominal pain Pallor, cold or clammy skin Confusion or altered consciousness These features may indicate significant blood loss requiring emergency intervention